Ubs Group Ag A Ikido Pharma Inc. Call Options Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AIKI
# of Institutions
25Shares Held
946KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA320KShares$1.22 Million0.0% of portfolio
-
Connective Capital Management, LLC Palo Alto, CA266KShares$1.01 Million1.35% of portfolio
-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.3KShares$251,8750.0% of portfolio
-
State Street Corp Boston, MA30.9KShares$117,3660.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...